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As waiting lists for lung transplantation are ever increasing, the number of organ donors is not able to keep pace
with it. Living donor lobar lung transplantation is a source of organs which could be lifesaving in end-stage lung
disease patients who cannot wait for cadaveric organs due to deteriorating lung function and clinical condition.
Two young women with end stage cystic fibrosis received lobes from their relatives and an altruistic friend. They
are surviving for more than 12 and 14 years with good lung functions.
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Lung transplantationBackground
Living donor lobar lung transplantation (LDLLT) is
performed as a life-saving procedure for critically ill pa-
tients who are unlikely to survive the long wait for ca-
daveric lungs. It has been proved life saving for various
lung diseases and appears to provide similar or better
survival than cadaveric lung transplantation. We are
reporting two LDLLT recipients surviving for more than
a decade with good lung functions.Case presentation
Case 1
A 25 years old university graduate student diagnosed of
cystic fibrosis with pancreatic insufficiency in childhood
was started deteriorating clinically due to uncontrolled
infection in chest, not responding to multiple courses of
various intravenous antibiotics over 6 months. Her main
complaints were cough with copious green expectora-
tions and shortness of breath with which she could
barely manage her household work. After detailed clin-
ical examination and investigations, she was accepted
on the waiting list for lung transplantation. Following* Correspondence: drprashantis@rediffmail.com
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reproduction in any medium, provided the orrepeated respiratory infections, her lung function deteri-
orated rapidly (Forced vital capacity, FVC 28% and
forced expiratory volume in 1 s, FEV1 25%) and she be-
came bed ridden. As it became apparent that her clinical
condition was falling so fast that she will not survive a
waiting for suitable cadaveric donor lungs, her family
was given a choice of live related lobar lung transplant-
ation, for which it agreed. The donors were her bio-
logical father, aged 60 years (Height: 182 cm, weight:
87 kg) and real sister, aged 24 years (Height: 176 cm,
weight: 65 kg). The recipient height and weight were
164 cm and 53 Kg. The recipient, the right lobar donor
(father) and the left lobar donor (sister) were taken to
the different theatres with gap of half to one hour each,
in that order. The recipient had clamshell incision and
both the lungs were dissected. She was put on cardiopul-
monary bypass (CPB) and right pneumonectomy was
performed. The right lower lobectomy was performed in
father through right postero-lateral thoracotomy at the
same time and the lobe was brought to recipient theatre.
The bronchial anastomosis (4–0 PDS, continuous) was
followed by pulmonary artery (6–0 polypropelene,
interrupted) and pulmonary venous (6–0 polypropelene,
continuous) anastomoses. The left pneumonectomy was
performed in the recipient and the left lower lobe was
obtained from the sister and anastomosed in similar
fashion. The ischemic time for right side was 2 hoursLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cipient was weaned off CPB with modest inotropic sup-
port and nitric oxide and blood gases were suggestive of
good gas exchange. Immunosuppression protocol in
LDLLT was similar to cadaveric donor lung transplant-
ation, consisting of tacrolimus, mycophenolate mofetil
and prednisolone and was started in the patient on the
day of transplantation. Recipient was weaned off ventila-
tor in 48 hours, but had slow recovery and long inten-
sive care unit stay due to infection with Pseudomonas,
persistent pleural effusions, renal failure needing inter-
mittent hemofiltration for a month and early rejection
requiring re-intubation and methyl prednisolone pulse.
She was discharged home 3 months after surgery and
over another 6 moths her lung functions and exercise
tolerance kept improving steadily. Over the last 12 years
her respiratory function tests have fallen twice but bron-
chial biopsy never showed rejection. Her latest lung
function showed predicted FVC of 65% and predicted
FEV1 of 66%. Figure 1 shows her latest chest x-ray. She
is full time, efficient office worker. Post-operative period
was uneventful for both the donors who made fast and
excellent recovery and were discharged home on 8th day.
Case 2
Another woman of 34 years with cystic fibrosis related
end stage lung disease had complaints of cough, haem-
optysis, dyspnoea, early fatigue and was requiring noc-
turnal oxygen therapy. Her clinical condition and lung
function deteriorated rapidly following several repeated
bouts of respiratory infections. Implied, that it was diffi-
cult for her to wait for cadaveric donor organs, herFigure 1 Chest x-ray in case 1.family was given option of LDLLT. As her mother, who
already agreed to donate a lobe was only close relative
alive; her altruistic friend expressed a wish to donate a
lobe. She (Height: 164 cm, Weight: 50 kg) received a
right lower lobe from a 24 years old altruistic friend
(Height: 164 cm, Weight 72 kg) and a left lower lobe
from her biological mother, aged 54 years (Height:
154 cm, Weight: 80 kg) through a clamshell incision in a
way mentioned in case 1. The ischemic time for right
side was 2 and half hours while for left side it was 1 hour
and 20 minutes. The patient was weaned off ventilator
on third day; however her post-operative course was
complicated by fungal endophthalmitis requiring right
side evisceration. She was discharged after 2 months. At
the end of one year, she developed collapse of the right
lung due to stenosis of right bronchial anastomosis
which required endobronchial stenting. Her latest lung
function showed predicted FVC of 78.6% and predicted
FEV1 of 84% and she is leading a healthy life. Figure 2
shows her latest chest x-ray. Post-operative period was
uneventful for both the donors, the friend was discharged
on 5th while the mother on 7th day.
Discussion
Lung transplantation is now established as a treatment
option for end-stage pulmonary disease [1]. The demand
for organs is ever increasing and far exceeds the supply.
The number of suitable organ donors could be increased
by proper donor management, non-heart beating donor,
ex-vivo lung perfusion and LDLLT [2,3]. Usually, LDLLT
is a last option chosen to save critically ill patient with
end-stage pulmonary disease who cannot wait for organsFigure 2 Chest x-ray in case 2.
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tients had cystic fibrosis and had rapid deterioration of
their lung function which left us without any choice but
to offer them option of LDLLT with relatives as donors.
The ethical dilemma in LDLLT is whether family
members should be risked in order to save a relative [5].
Two lungs obtained from live donors can adequately
support an adult cystic fibrosis patient [6]. In our first
case, donors were 7–10% taller compared to recipient,
while in the second case they were equal or shorter than
the recipient. However, donor lower lobes filled up re-
cipient hemithorices adequately. LDLLT is severely lim-
ited by availability of suitable wishful donor in the
family. Most important criteria to be met is suitably
matching blood group. If more than one wishful donor
in family meets this criteria, then height, weight and age
matching comes in picture. Size mismatching can be
overcome to a certain extent using various surgical tech-
niques, however they were not required in the present
cases [4]. Although LDLLT may be associated with the
limitation of size mismatch, it holds promise for provid-
ing well-functioning pulmonary lobar grafts to critically
ill patients with poor life expectancy [7]. The donor pro-
cedure is safe with minimum morbidity, well tolerated
physiologically, and the great majority of donors are ex-
tremely satisfied with their decision to donate [6,8]. In
two recent large LDLLT series, there was no mortality in
live lobar donors and 15–20% donors suffered some kind
of morbidity which is acceptable and similar to the
standard lung resection; moreover donor pulmonary
function was found well preserved [9,10]. In present
cases, the donors made excellent recovery without any
complication and are experiencing healthy lifestyle more
than a decade after surgery. LDLLT provides acceptable
long-term survival when compared to recipients of ca-
daveric grafts [8]. This could possibly be because of
avoidance of organ transport on ice, thus preserving the
grafts structurally and functionally as well as less chance
of rejection, probably because of sharing genetic pool
with the donors. In our first case, the donors were recip-
ient’s first relatives and she never had biopsy proven re-
jection in any of the donated lobes. After 12 years of
transplantation, she is following up with good lung func-
tion tests and having near-normal lifestyle. In our sec-
ond case, although one of the donors was not related to
the recipient biologically, she never had biopsy proven
rejection and shown consistently good lung function
since 14 years of transplantation.
In case of lung transplantation, the breathing capacity
and exercise tolerance increases initially after surgery,
then plateau and after 5–7 years and then starts decreas-
ing as transplanted lungs inevitably develop bronchiolitis
obliterans. Interestingly, in both our LDLLT recipients
lung function has improved over time and recipients feelthat the breathing and exercise capacity has increased
over the years and it was always better than before.
These two cases do not represent our institute’s experi-
ence of LDLLT, but embodies good outcome and long
term survival in patients undergoing LDLLT.
Conclusions
LDLLT is a source of organs which could be life saving
in end-stage lung disease patients who are likely to die
on list waiting for cadaveric organs. As the procedure in-
volves risk to healthy donors, proper assessment of family
members as a donor, appropriate recipient-donor size
matching and superlative timing of recipient-donor surger-
ies is a key to success. Although cadaveric donors remain
the main source of organs, LDLLT should continue to be
used under properly selected circumstances, to maintain
the viability of this potentially life-saving procedure.
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